Table 1 Baseline characteristics of all patients with non-metastatic bladder cancer and patients who died according to the time of death after diagnosis

Overall

24,074

4,179 (100)

77.93

2,289 (54.8)

78.49

1,890 (45.2)

77.25

 0–49

1,037

59 (100)

45.9

31 (52.5)

45.31

28 (47.5)

46.56

 50–64

6,394

649 (100)

60.49

303 (46.7)

60.13

346 (53.3)

60.81

  > 64

16,643

3,471 (100)

81.73

1,955 (56.3)

81.86

1,516 (43.7)

81.57

 White

21,432

3,639 (100)

78.22

1,991 (54.7)

78.71

1,648 (45.3)

77.64

 Black

1,352

306 (100)

73.35

171 (55.9)

74.95

135 (44.1)

71.33

 Asian or Pacific Islander

1,201

206 (100)

79.98

108 (52.4)

80.98

98 (47.6)

78.87

 American Indian/Alaska Native

89

28 (100)

74.59

19 (67.9)

73.21

9 (32.1)

77.51

 In situ

12,940

935 (100)

80.25

403 (43.1)

80.32

532 (56.9)

80.20

 Localized

8,574

2,051 (100)

79.26

1,154 (56.3)

79.91

897 (43.7)

78.41

 Regional

1,814

839 (100)

72.56

496 (59.1)

74.26

343 (40.9)

70.11

 Grade I

1,970

161 (100)

79.8

63 (39.1)

78.89

98 (60.9)

80.39

 Grade II

6,232

447 (100)

79.07

214 (47.9)

79.18

233 (52.1)

78.97

 Grade III

2,278

615 (100)

77.36

357 (58.0)

77.96

258 (42.0)

76.52

 Grade IV

9,598

2,244 (100)

76.85

1,236 (55.1)

77.58

1,008 (44.9)

75.96

 Yes

22,699

3,739 (100)

77.58

1,996 (53.4)

78.13

1,743 (46.6)

76.95

 Yes

1,000

477 (100)

78.69

259 (54.3)

79.34

218 (45.7)

77.92

 Yes

7,186

1,290 (100)

73.18

590 (45.7)

73.62

700 (54.3)

72.81